Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate Extended-release Capsule, Extended Release
Product Images NDC 42858-930

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate Extended-release (NDC 42858-930). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rhodes Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Amphetamine 01)

FDA Label Image

Principal Display Panel (5 mg Capsule Bottle Label)

This text appears to be a description of prescription medication in capsule form called "Dextroamphetamine". It contains a mixture of salts of a single-entity amphetamine product, namely Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate, and is in extended-release form. The medication is marketed by Prides Pharmaceuticals in Coventry and is accompanied by a medication guide that should be provided to each patient. The box contains 100 capsules and the NDC code is £2856-055.01.*

FDA Label Image

Principal Display Panel (10 mg Capsule Bottle Label)

This is a description of a medication in the form of extended-release capsules that contains Dextroamphetamine as one of its ingredients, along with Saccharate, Aspartate Monohydrate, and Amphetamine Sulfate. The medication is marketed by ANodes Pharmacasscals L., and is packaged with an accompanying medication guide for each patient. The NDC code for the medication is 42858-610-01 and it comes in a pack of 100 capsules.*

FDA Label Image

Principal Display Panel (15 mg Capsule Bottle Label)

This is a medication with the National Drug Code (NDC) 42858-215-01 indicated on the label. The medication is Extended-Release Capsules of a Single-Entity Amphetamine Product that contains Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate. It comes with a Medication Guide that the pharmacist should dispense to each patient. The document includes a lot number and batch number but does not provide any details about its uses or effects.*

FDA Label Image

Principal Display Panel (20 mg Capsule Bottle Label)

This is a description for a medication with the NDC number 42858-720-01, called Dextroamphetamine. It contains a mix of saccharate, aspartate monohydrate, sulfate, and amphetamine sulfate in extended-release capsules. The medication is produced by Aves Pharmaceuticals in the US. A pharmacist is advised to give the accompanying medication guide to each patient. There are 100 capsules in the bottle.*

FDA Label Image

Principal Display Panel (25 mg Capsule Bottle Label)

This is a drug label for Extended-Release Capsules containing amphetamine salts such as Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate, to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. The medication guide should be provided to each patient by the pharmacist. The manufacturer is Rhodes Pharmaceuticals LP. The label provides information on the contents of each capsule and the equivalence to amphetamine base.*

FDA Label Image

Principal Display Panel (30 mg Capsule Bottle Label)

This is a description of a medication with the NDC number 42853-930-01, called Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release Capsules. It is a mixed salts of a single-entity amphetamine product used as a treatment for ADHD and narcolepsy. The medication is marketed by Rhodes Pharmaceuticals and each capsule contains 18.8mg of amphetamine base equivalent with a total of 100 capsules per package.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.